Page last updated: 2024-08-23

phenyl acetate and Abdominal Aortic Aneurysm

phenyl acetate has been researched along with Abdominal Aortic Aneurysm in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araújo, AC; Busch, A; Caidahl, K; Di Gennaro, A; Eriksson, P; Haeggström, JZ; Jin, H; Maegdefessel, L; Samuelsson, B; Vorkapic, E; Wågsäter, D1
Araújo, AC; Haeggström, JZ; Tang, X1

Reviews

1 review(s) available for phenyl acetate and Abdominal Aortic Aneurysm

ArticleYear
Targeting cysteinyl-leukotrienes in abdominal aortic aneurysm.
    Prostaglandins & other lipid mediators, 2018, Volume: 139

    Topics: Acetates; Aortic Aneurysm, Abdominal; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Blood Vessels; Cyclopropanes; Cysteine; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Receptors, Leukotriene; Sulfides; Thrombosis

2018

Other Studies

1 other study(ies) available for phenyl acetate and Abdominal Aortic Aneurysm

ArticleYear
Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm.
    Proceedings of the National Academy of Sciences of the United States of America, 2018, 02-20, Volume: 115, Issue:8

    Topics: Acetates; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Chemokine CCL3; Cyclopropanes; Disease Models, Animal; Leukotriene Antagonists; Matrix Metalloproteinase 9; Mice; Mice, Knockout, ApoE; Quinolines; Receptors, Leukotriene; Sulfides

2018